SPC374
Finerenón og sölt þess, lausnarsambönd og lausnarsambönd af söltunum þar af
Status:
VeittApplication date:
9.5.2022Application published:
15.6.2022Grant published:
15.7.2023
Max expiry date:
18.2.2033Medicine name:
KerendiaMedicine for children:
No
Timeline
Today
9.5.2022Application
15.6.2022Publication
15.7.2023Registration
18.2.2033Expires
Marketing license
IS authorization number:
EU/1/21/1616/001-005; EU/1/21/1616/006-010Date:
24.2.2022
Foreign authorization number:
EU/1/21/1616Date:
17.2.2022
Owner
Name:
Bayer Intellectual Property GmbHAddress:
Alfred-Nobel-Strasse 50, Monheim am Rhein DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2132206